Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sustained-release formulations for treating CNS-mediated disorders

Sustained-release formulations for treating CNS-mediated disorders

US Patent 7235258 · Granted Jun 26, 2007

Estimated economic value: $2,071,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods 2025
Nasal and ophthalmic delivery of aqueous corticosteroid solutions2025
DPI formulation containing sulfoalkyl ether cyclodextrin2022
Composition containing sulfoalkyl ether cyclodextrin and latanoprost2022
Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods 2022
Injectable nitrogen mustard compositions comprising a cyclodextrin derivative an2021
Injectable melphalan compositions comprising a cyclodextrin derivative and metho2021
Injectable nitrogen mustard compositions comprising a cyclodextrin derivative an2020
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid2020
Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods 2020
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof2020
System and method for processing and forwarding transmitted information2020